Youngen Biotech

Youngene Biotech is a clinical-stage biopharmaceutical company based in Shanghai, China, specializing in the discovery and development of innovative antibody therapeutics for autoimmune and inflammatory diseases. The company focuses on high-value targets within the cytokine signaling pathways, such as IL-17, IL-4Rα, and IL-5, to treat conditions like psoriasis, atopic dermatitis, and asthma. Youngene leverages its proprietary antibody engineering platforms to develop differentiated biologics, including bispecific antibodies, aimed at providing superior efficacy and safety profiles. With several programs in mid-stage clinical trials, the company is positioning itself as a significant player in the Chinese immunology and inflammation market.